{
    "info": {
        "nct_id": "NCT05605899",
        "official_title": "An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel Versus Standard of Care Therapy as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-23)",
        "inclusion_criteria": "* Histologically confirmed large B cell lymphoma (LBCL) based on 2016 World Health Organization (WHO) classification by local pathology lab assessment, including of the following:\n\n  * Diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS)\n  * High-grade B-cell lymphoma (HGBL)\n* Note: Transformed DLBCL from follicular lymphoma or from marginal zone lymphoma is eligible if no prior treatment with anthracycline-containing regimen.\n* High-risk disease defined as an International Prognostic Index (IPI) score of 4 or 5 at initial diagnosis.\n* Have received only 1 cycle of rituximab plus chemotherapy (R-chemotherapy).\n* Adequate bone marrow, renal, hepatic, pulmonary, and cardiac function.\n* Females of childbearing potential must have a negative serum or urine pregnancy test.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* The following WHO 2016 subcategories by local assessment:\n\n  * T-cell/histiocyte-rich LBCL\n  * Primary DLBCL of the central nervous system (CNS)\n  * Primary mediastinal (thymic) LBCL\n  * B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma\n  * Burkitt lymphoma\n  * History of Richter's transformation of chronic lymphocytic leukemia\n* Presence of detectable cerebrospinal fluid (CSF)-malignant cells, brain metastases, or a history of CNS involvement of lymphoma.\n* Presence of cardiac lymphoma involvement.\n* Any prior treatment for LBCL other than the 1 cycle of R-chemotherapy.\n* History of severe immediate hypersensitivity reaction to any of the agents used in this study.\n* Presence of CNS disorder. History of stroke, transient ischemic attack, or posterior reversible encephalopathy syndrome (PRES) within 12 months prior to enrollment.\n* History of acute or chronic active hepatitis B or C infection.\n* Positive for human immunodeficiency virus (HIV) unless taking appropriate anti-HIV medications, with an undetectable viral load by PCR and with a cluster of differentiation 4 (CD4) count > 200 cells/uL.\n* Medical conditions or residual toxicities from prior therapies likely to interfere with assessment of safety or efficacy of study treatment. Please refer to protocol for further details.\n* History of clinically significant cardiac disease within 12 months before enrollment.\n* History of any medical condition requiring maintenance systemic immunosuppression/systemic disease modifying agents within the last 2 years.\n\nNote: Other protocol defined Inclusion/Exclusion criteria may apply.",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "* Diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS)",
            "criterions": [
                {
                    "exact_snippets": "Diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS)",
                    "criterion": "diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* High-grade B-cell lymphoma (HGBL)",
            "criterions": [
                {
                    "exact_snippets": "High-grade B-cell lymphoma (HGBL)",
                    "criterion": "high-grade B-cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "key"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate bone marrow, renal, hepatic, pulmonary, and cardiac function.",
            "criterions": [
                {
                    "exact_snippets": "Adequate bone marrow ... function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... renal ... function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hepatic ... function",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... pulmonary ... function",
                    "criterion": "pulmonary function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... cardiac function",
                    "criterion": "cardiac function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have received only 1 cycle of rituximab plus chemotherapy (R-chemotherapy).",
            "criterions": [
                {
                    "exact_snippets": "Have received only 1 cycle of rituximab plus chemotherapy (R-chemotherapy)",
                    "criterion": "number of cycles of rituximab plus chemotherapy received",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "cycle"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Note: Transformed DLBCL from follicular lymphoma or from marginal zone lymphoma is eligible if no prior treatment with anthracycline-containing regimen.",
            "criterions": [
                {
                    "exact_snippets": "Transformed DLBCL from follicular lymphoma or from marginal zone lymphoma is eligible",
                    "criterion": "transformed DLBCL from follicular lymphoma or from marginal zone lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if no prior treatment with anthracycline-containing regimen",
                    "criterion": "prior treatment with anthracycline-containing regimen",
                    "requirements": [
                        {
                            "requirement_type": "history of prior treatment",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* High-risk disease defined as an International Prognostic Index (IPI) score of 4 or 5 at initial diagnosis.",
            "criterions": [
                {
                    "exact_snippets": "High-risk disease defined as an International Prognostic Index (IPI) score of 4 or 5 at initial diagnosis.",
                    "criterion": "International Prognostic Index (IPI) score",
                    "requirements": [
                        {
                            "requirement_type": "value at initial diagnosis",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Females of childbearing potential must have a negative serum or urine pregnancy test.",
            "criterions": [
                {
                    "exact_snippets": "Females of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative serum or urine pregnancy test",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "serum",
                                "urine"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically confirmed large B cell lymphoma (LBCL) based on 2016 World Health Organization (WHO) classification by local pathology lab assessment, including of the following:",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed large B cell lymphoma (LBCL)",
                    "criterion": "large B cell lymphoma (LBCL)",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "based on 2016 World Health Organization (WHO) classification",
                    "criterion": "LBCL classification",
                    "requirements": [
                        {
                            "requirement_type": "classification system",
                            "expected_value": "2016 World Health Organization (WHO)"
                        }
                    ]
                },
                {
                    "exact_snippets": "by local pathology lab assessment",
                    "criterion": "pathology lab assessment",
                    "requirements": [
                        {
                            "requirement_type": "assessment location",
                            "expected_value": "local pathology lab"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Primary mediastinal (thymic) LBCL",
            "criterions": [
                {
                    "exact_snippets": "Primary mediastinal (thymic) LBCL",
                    "criterion": "primary mediastinal (thymic) large B-cell lymphoma (LBCL)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Positive for human immunodeficiency virus (HIV) unless taking appropriate anti-HIV medications, with an undetectable viral load by PCR and with a cluster of differentiation 4 (CD4) count > 200 cells/uL.",
            "criterions": [
                {
                    "exact_snippets": "Positive for human immunodeficiency virus (HIV)",
                    "criterion": "HIV status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unless taking appropriate anti-HIV medications",
                    "criterion": "anti-HIV medication use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with an undetectable viral load by PCR",
                    "criterion": "HIV viral load by PCR",
                    "requirements": [
                        {
                            "requirement_type": "detectability",
                            "expected_value": "undetectable"
                        }
                    ]
                },
                {
                    "exact_snippets": "with a cluster of differentiation 4 (CD4) count > 200 cells/uL",
                    "criterion": "CD4 count",
                    "requirements": [
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">",
                                "value": 200,
                                "unit": "cells/uL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of Richter's transformation of chronic lymphocytic leukemia",
            "criterions": [
                {
                    "exact_snippets": "History of Richter's transformation of chronic lymphocytic leukemia",
                    "criterion": "Richter's transformation of chronic lymphocytic leukemia",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Primary DLBCL of the central nervous system (CNS)",
            "criterions": [
                {
                    "exact_snippets": "Primary DLBCL of the central nervous system (CNS)",
                    "criterion": "primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Burkitt lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Burkitt lymphoma",
                    "criterion": "Burkitt lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of severe immediate hypersensitivity reaction to any of the agents used in this study.",
            "criterions": [
                {
                    "exact_snippets": "History of severe immediate hypersensitivity reaction to any of the agents used in this study.",
                    "criterion": "hypersensitivity reaction to study agents",
                    "requirements": [
                        {
                            "requirement_type": "history of severe immediate hypersensitivity reaction",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma",
            "criterions": [
                {
                    "exact_snippets": "B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma",
                    "criterion": "B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of acute or chronic active hepatitis B or C infection.",
            "criterions": [
                {
                    "exact_snippets": "History of acute or chronic active hepatitis B or C infection.",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": [
                                "acute",
                                "chronic active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "History of acute or chronic active hepatitis B or C infection.",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": [
                                "acute",
                                "chronic active"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of CNS disorder. History of stroke, transient ischemic attack, or posterior reversible encephalopathy syndrome (PRES) within 12 months prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Presence of CNS disorder",
                    "criterion": "CNS disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of stroke ... within 12 months prior to enrollment",
                    "criterion": "stroke",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... transient ischemic attack ... within 12 months prior to enrollment",
                    "criterion": "transient ischemic attack",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... posterior reversible encephalopathy syndrome (PRES) within 12 months prior to enrollment",
                    "criterion": "posterior reversible encephalopathy syndrome (PRES)",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The following WHO 2016 subcategories by local assessment:",
            "criterions": [
                {
                    "exact_snippets": "WHO 2016 subcategories by local assessment",
                    "criterion": "WHO 2016 subcategory",
                    "requirements": [
                        {
                            "requirement_type": "classification",
                            "expected_value": "as per local assessment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any prior treatment for LBCL other than the 1 cycle of R-chemotherapy.",
            "criterions": [
                {
                    "exact_snippets": "Any prior treatment for LBCL other than the 1 cycle of R-chemotherapy.",
                    "criterion": "prior treatment for LBCL",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "1 cycle of R-chemotherapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of clinically significant cardiac disease within 12 months before enrollment.",
            "criterions": [
                {
                    "exact_snippets": "History of clinically significant cardiac disease within 12 months before enrollment.",
                    "criterion": "clinically significant cardiac disease",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months before enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* T-cell/histiocyte-rich LBCL",
            "criterions": [
                {
                    "exact_snippets": "T-cell/histiocyte-rich LBCL",
                    "criterion": "T-cell/histiocyte-rich large B-cell lymphoma (LBCL)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of detectable cerebrospinal fluid (CSF)-malignant cells, brain metastases, or a history of CNS involvement of lymphoma.",
            "criterions": [
                {
                    "exact_snippets": "Presence of detectable cerebrospinal fluid (CSF)-malignant cells",
                    "criterion": "cerebrospinal fluid (CSF)-malignant cells",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "detectability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of CNS involvement of lymphoma",
                    "criterion": "CNS involvement of lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of cardiac lymphoma involvement.",
            "criterions": [
                {
                    "exact_snippets": "Presence of cardiac lymphoma involvement",
                    "criterion": "cardiac lymphoma involvement",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of any medical condition requiring maintenance systemic immunosuppression/systemic disease modifying agents within the last 2 years.",
            "criterions": [
                {
                    "exact_snippets": "History of any medical condition requiring maintenance systemic immunosuppression/systemic disease modifying agents within the last 2 years.",
                    "criterion": "medical condition requiring maintenance systemic immunosuppression",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "maintenance systemic immunosuppression"
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of any medical condition requiring maintenance systemic immunosuppression/systemic disease modifying agents within the last 2 years.",
                    "criterion": "medical condition requiring maintenance systemic disease modifying agents",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "maintenance systemic disease modifying agents"
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Medical conditions or residual toxicities from prior therapies likely to interfere with assessment of safety or efficacy of study treatment. Please refer to protocol for further details.",
            "criterions": [
                {
                    "exact_snippets": "Medical conditions or residual toxicities from prior therapies likely to interfere with assessment of safety or efficacy of study treatment",
                    "criterion": "medical conditions or residual toxicities from prior therapies",
                    "requirements": [
                        {
                            "requirement_type": "likelihood to interfere with assessment of safety or efficacy of study treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "key"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "Note: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "criterions": []
        }
    ],
    "failed_miscellaneous": []
}